| 1 |
Gonzalez-Vicent M, Sanz J, Luis Fuster J, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): A retrospective analysis and a proposal of treatment on behalf of the Grupo Espanol De Trasplante de Medula Osea en Nimos (GETMON) and the Grupo Espanol de Trasplante Hematopoyetico (GETH)[J]. Transfus Med Rev, 2018, 32(3):179-185.
|
| 2 |
Page KM, Mendizabal AM, Prasad VK, et al. Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation[J]. Biol Blood Marrow Transplant, 2008, 14(10):1108-1117.
|
| 3 |
Wang M, Wang W, Abeywardane A, et al. Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at king's college hospital[J]. Biol Blood Marrow Transplant, 2015, 21(1):60-66.
|
| 4 |
Faraci M, Zecca M, Pillon M, et al. Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children:an Italian multicenter experience[J]. Biol Blood Marrow Transplant, 2014, 20(2):272-278.
|
| 5 |
O'brien TA, Eastlund T, Peters C, et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases[J]. Br J Haematol, 2004, 127(1):67-75.
|
| 6 |
Sanz J, Arango M, Carpio N, et al. Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience[J]. Bone Marrow Transplant, 2014, 49(8):1084-1088.
|
| 7 |
Lv WR, Liu QF, Fan ZP, et al. Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor[J]. Blood, 2016, 128(22):26505-26514.
|
| 8 |
Barcellini W. Current treatment strategies in autoimmune hemolytic disorders[J]. Expert Rev Hematol, 2015, 8(5):681-691.
|
| 9 |
中华医学会血液学分会红细胞疾病(贫血)学组. 自身免疫性溶血性贫血诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(4): 265-267.
|
| 10 |
Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias[J]. Haematologica, 2014, 99(10):1547-1554.
|
| 11 |
王超，薛胜利，李正, 等. 异基因造血干细胞移植后自身免疫性溶血性贫血一例并文献复习[J]. 白血病·淋巴瘤, 2018, 27(4):228-233,237.
|
| 12 |
Halligan K, Vasiljevic L, Roehrs P, et al. Use of eculizumab in a patient with refractory autoimmune hemolytic anemia with heterozygous NFκB1 mutation[J]. Blood, 2017, 130(1):4743.
|
| 13 |
Crowther M, Chan Y, Garbett IK, et al. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults[J]. Blood, 2011, 118(15):4036-4040.
|
| 14 |
Bisharat N, Omari H, Lavi I, et al. Risk of infection and death among post-splenectomy patients[J]. J Infect, 2001,43(3):182-186.
|
| 15 |
Hosoba S, Jaye DL, Cohen C, et al. Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature[J]. Transfusion, 2015, 55(2):259-264.
|
| 16 |
Pimentel-Quiroz VR, Ugarte-Gil MF, Alarcon GS. Abatacept for the treatment of systemic lupus erythematosus[J]. Expert Opin Investig Drugs, 2016, 25(4):493-499.
|
| 17 |
Visentini M, Tinelli C, Colantuono S, et al. Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review[J]. Autoimmun Rev, 2015, 14: 889-896.
|
| 18 |
Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients[J]. Blood, 2014, 124(19):2930-2936.
|
| 19 |
高清妍，刘晨曦，李园, 等. 小剂量利妥昔单抗治疗12例难治/复发原发性自身免疫性溶血性贫血患者疗效分析[J]. 中华血液学杂志, 2017, 38(12):1075-1077.
|
| 20 |
Barcellini W, Fattizzo B, Zaninoni A. Current and emerging treatment options for autoimmune hemolytic anemia[J]. Expert Rev Clin Immunol, 2018, 14(10):857-872.
|
| 21 |
Li X, Huang J, Zhu Z, et al. Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab[J]. J Int Med Res, 2019, 47(7):3320-3331.
|
| 22 |
Lechner K, Jaeger U. How I treat autoimmune hemolytic anemias in adults[J]. Blood, 2010, 116(11):1831-1838.
|
| 23 |
Schuetz C, Hoenig M, Moshous D, et al. Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation[J]. Blood, 2018, 2(19):2550-2553.
|
| 24 |
O'connell N, Goodyer M, Gleeson M, et al. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation[J]. Pediatr Transplant, 2014, 18(1):E22-E24.
|
| 25 |
Park JA, Lee HH, Kwon HS, et al. Sirolimus for refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: a case report and literature review of the treatment of Post-Transplant autoimmune hemolytic anemia[J]. Transfus Med Rev, 2016, 30(1):6-14.
|
| 26 |
Hess J, Su L, Nizzi F, et al. Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept[J]. Transfusion, 2018, 58(9):2122-2127.
|
| 27 |
Anderson D, Ali K, Blanchette V, et al. Guidelines on the use of intravenous immune globulin for hematologic conditions[J]. Transfus Med Rev, 2007, 21(2, 1):S9-S56.
|
| 28 |
Hartert A, Willenbacher W, Gunzelmann S, et al. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT[J]. Bone Marrow Transplant, 2001, 27(3):337-340.
|
| 29 |
Ruivard M, Tournilach O, Montel S, et al. Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case-control study[J]. J Clin Apher, 2006, 21: 202-206.
|